Advertisement

Topics

AZ gets EMA green light for severe asthma drug Fasenra

06:09 EST 11 Jan 2018 | PMLIVE

The biologic respiratory treatment will go up against GSK’s Nucala and Teva’s Cinqaero

Original Article: AZ gets EMA green light for severe asthma drug Fasenra

NEXT ARTICLE

More From BioPortfolio on "AZ gets EMA green light for severe asthma drug Fasenra"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...